This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Artem Lebedev: Innovator in Radiopharmaceuticals
Introduction
Artem Lebedev is a prominent inventor based in Los Angeles, CA (US). He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods for the electrochemical fluorination of aromatic molecules. His work has the potential to enhance the efficiency and accessibility of essential compounds used in medical imaging.
Latest Patents
Artem Lebedev holds a patent for the "Synthesis of fluorinated radiopharmaceuticals via electrochemical fluorination." This invention provides methods and compositions for the electrochemical selective radiofluorination of aromatic molecules. The resulting fluorine-18 labeled compounds are ideal radionuclides for use in Positron Emission Tomography (PET). They are particularly valuable as they can be produced with high radiochemical yield and specific activity, addressing the challenges associated with existing approaches.
Career Highlights
Lebedev's career is marked by his dedication to advancing medical imaging technologies. His innovative approach to synthesizing radiopharmaceuticals has opened new avenues for research and clinical applications. He is affiliated with the University of California, where he continues to contribute to the scientific community.
Collaborations
Artem Lebedev has collaborated with notable colleagues, including Saman Sadeghi and Qinggang He. These partnerships have further enriched his research and development efforts in the field of radiopharmaceuticals.
Conclusion
Artem Lebedev's work in the synthesis of fluorinated radiopharmaceuticals represents a significant advancement in medical imaging technology. His innovative methods promise to improve the availability and efficiency of essential PET tracers, ultimately benefiting the field of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
